On December 19, 2016, AbbVie announced its New Drug Application submission for G/P to the U.S. Food and Drug Administration (FDA) for the treatment of GT1-6 chronic HCV infection. AbbVie has also ...
Gilead Sciences, Inc.GILD announced that its Marketing Authorization Application (MAA) for experimental direct-acting antiviral (DAA) of once-daily, single tablet regimen (STR) of Sovaldi, velpatasvir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback